Fertility and Sterility
Volume 94, Issue 4 , Pages 1178-1180, September 2010

2009 H1N1 influenza prevention and treatment: counseling infertility patients

  • Connie E. Alford, M.D.

      Affiliations

    • Program in Reproductive and Adult Endocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, Maryland
    • Corresponding Author InformationReprint requests: Connie E. Alford, M.D., Program in Reproductive and Adult Endocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Building 10 Clinical Resource Center, Room 1E-3140, 10 Center Drive, MSC 1109, Bethesda, Maryland 20892-1109 (FAX: 301-402-0884).
  • ,
  • Grace L. Chen, M.D., M.P.H.

      Affiliations

    • National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland
  • ,
  • Alicia Y. Armstrong, M.D., M.H.S.C.R.

      Affiliations

    • Program in Reproductive and Adult Endocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, Maryland

Received 27 January 2010; received in revised form 21 April 2010; accepted 23 April 2010. published online 24 June 2010.

It is known that pregnant women are at high risk for complications from the 2009 H1N1 influenza virus. Reproductive endocrinologists often have the opportunity to evaluate patients before conception and are able to counsel them before they become part of this high-risk obstetrics group. The 2009 H1N1 vaccine data and the current recommendations by the Centers for Disease Control and Prevention, American College of Obstetrics and Gynecology, and American Society of Reproductive Medicine are discussed. There is universal agreement in recommending vaccination for all pregnant women and all women attempting conception. Patients should be counseled regarding the vaccine and consider delaying conception until the immunization has been received.

Key Words: H1N1, H1N1 influenza virus, H1N1 influenza vaccine, H1N1 influenza treatment, pregnancy, infertility, preconception counseling

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 C.E.A. has nothing to disclose. G.L.C. has nothing to disclose. A.Y.A. has nothing to disclose.

 Supported, in part, by the Program in Reproductive and Adult Endocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development.

PII: S0015-0282(10)00694-1

doi:10.1016/j.fertnstert.2010.04.056

Fertility and Sterility
Volume 94, Issue 4 , Pages 1178-1180, September 2010